Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Energy Department Helps Fund Six CO2 Capture Pilot Projects

The U.S. Department of Energy (DoE) will help fund six projects that aim to convert captured carbon dioxide (CO2) emissions from industrial sources into useful products such as fuel, plastics, cement, and fertilizers. DoE will contribute $106 million in American Recovery and Reinvestment Act funds, combined with $156 million in private cost sharing.

The projects . . . → Read More: Energy Department Helps Fund Six CO2 Capture Pilot Projects

Canada Awards Grants to Solar Energy and Genomics Companies

National Research Council of Canada, through its Industrial Research Assistance Program, awarded grants to Boreal Genomics Inc. of Vancouver, British Columbia, and Day4 Energy Inc. of Burnaby, British Columbia. The grants, totaling $CAD769,000, were awarded to support research and development projects that build high-tech solutions for global markets.

Day4 Energy received $496,000 to develop a . . . → Read More: Canada Awards Grants to Solar Energy and Genomics Companies

Clinical Trial Shows Promise of Immune Therapy HIV Vaccine

(U.S. Army Corps of Engineers)

Two researchers gave findings from a Phase II clinical trial, sponsored by FIT Biotech, a biotechnology company in Tampere, Finland, showing the company’s immunomodulator FIT-06 vaccine offered long-term reductions in viral load and statistically significant CD4 (white blood or T) cell count increases in HIV-infected, previously untreated patients. . . . → Read More: Clinical Trial Shows Promise of Immune Therapy HIV Vaccine

Financing Deals: 22 July 2010

AxioMed Spine Corporation, a spinal orthopedics company developing products to restore spinal function in patients with degenerative spine disease, announced today that it has raised $14.5 million in two tranches from both current and new investors, not identified by the company. The funding will provide AxioMed with the ability to complete a study in the . . . → Read More: Financing Deals: 22 July 2010

NIH Seeking Small Business Proposals for HazMat Training

(Linda Bartlett, National Cancer Institute)

The National Institute of Environmental Health Sciences (NIEHS) wants ideas from small businesses for using advanced technology to train HazMat workers and emergency responders to better protect themselves and their communities from hazardous materials. NIEHS, part of National Institutes of Health, has issued a funding announcement seeking applications . . . → Read More: NIH Seeking Small Business Proposals for HazMat Training

Acute Radiation Syndrome Drug Granted FDA Fast Track Status

Cleveland BioLabs Inc., a biotechnology company in Buffalo, New York, today announced that CBLB502, a drug developed for the treatment of acute radiation syndrome (ARS), has been granted fast track status by the U.S. Food and Drug Administration (FDA).

CBLB502 is derived from a microbial protein that can reduce injury from acute stresses, such as . . . → Read More: Acute Radiation Syndrome Drug Granted FDA Fast Track Status

Study Shows Impact of Manufacturing R&D in Michigan

The Detroit News reports today on a new study by the Anderson Economic Group, a consulting firm in East Lansing, Michigan, that gauges the financial impact of the University Research Corridor (URC), a consortium of Michigan’s three largest universities on the state: Michigan State University, the University of Michigan, and Wayne State University.

The report . . . → Read More: Study Shows Impact of Manufacturing R&D in Michigan

NIH Extends Comment Period on New Conflict Regulations

National Institutes of Health (NIH) extended the comment period on proposed conflict-of-interest rules for researchers to 19 August 2010. The extended period on the new rules, officially known as “Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought and Responsible Prospective Contractors,” seeks comments on specific topics that arose since . . . → Read More: NIH Extends Comment Period on New Conflict Regulations

GE, Sloan-Kettering to Study Early Stage Colon Cancer

Colon cancer tissue stained for a biomarker linked to poor patient outcome. (GE Global Research)

A team of scientists at GE Global Research, the technology development arm of the manufacturing and finance company GE, has begun a study with Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, N.Y., to better understand the early . . . → Read More: GE, Sloan-Kettering to Study Early Stage Colon Cancer

New Patent Application Filed for Pyrolysis Oil Biofuel

Renewable fuels provider New Generation Biofuels (NGBF) in Columbia, Maryland said today it has filed a patent application for their new pyrolysis oil based biofuels. Pyrolysis oil is a synthetic fuel extracted through a technology that converts biomass to liquid under extreme heat in the absence of oxygen.

“We have been able to readily and . . . → Read More: New Patent Application Filed for Pyrolysis Oil Biofuel